Summary of Proposed Investment
Project Number
8994
Company Name
Distribuidora Cesar Guerrero Lejarza S.A.
Date SPI Disclosed
Jun 18, 1998
Country
Nicaragua
Industry
Agribusiness and Forestry
Status
Completed
Sector
Wholesale (Including Grocery and Farm Products)
Department
Regional Industry MAS LAC & EUR
Environmental Category
B - Limited
Previous Events
Approved : Nov 18, 1998
Signed : Dec 18, 1998
Invested : Apr 2, 1999
Project Description
Summary Of Project Information (SPI)
| Project Name | Nicaragua - DICEGSA |
| Region | Latin America and Caribbean |
| Sector |
Projected Board DateJuly 18, 1998
Company NameDICEGSA, S.A. and CEGUEL, S.A.
Technical Partner and/or Major Shareholders
The Company is owned by the Guerrero family of Nicaragua.
Project Cost Including proposed IFC investment
US$2.6 million. IFC is contributing US$1.3 million in long-term debt (A Loan).
Location of project and Description of site
The site where the new warehouse and office headquarter complex will be constructed is about a mile from Dicegsa''s current site, which is located in Managua. The site is about 9,000 square meters. The facilities will consist of a one-level 2,300 square meter warehouse, and an 800 square meter two-level office area. Ceguel''s laboratory is located in the outskirts of Granada. It consists of a 1,000 square meter building and 600 square meter warehouse.
Description of Company and Purpose of Project
Dicegsa is the largest distributor of pharmaceutical goods in Nicaragua. The project consists of constructing a new warehouse and office headquarters complex to expand and modernize Dicegsa''s wholesale distribution operations, and to expand their distribution vehicle fleet. The second component of the project includes the expansion and modernization of Dicegsa''s pharmaceutical production subsidiary, Ceguel S.A., which produces pharmaceuticals that are complementary to Dicegsa''s imported products.
Environmental Category and Issues
This is a category B project according to IFC''S environmental review procedure. Key environmental, occupational health and safety issues that were of potential concern during IFC''S environmental review of this project included: air emissions; treatment and disposal of process effluent; disposal of pharmaceutical-related waste; disposal of solid, and other liquid wastes, including sewage; source of water and power, including fuel storage if applicable; employee exposure to dust and noise; provision of personal protective equipment; health and safety training for employees; and fire safety. No air emission will be released to the atmosphere. Wastewater treatment will be installed to ensure released waters will comply with World Bank Guidelines. Work environment will be controlled and personal protective equipment will be provided to and required to use by the employees. The plant will have fire emergency systems in place. The project has been designed to comply with World Bank Guidelines and Policies.
The is from the InfoShop.
| Date SPI sent to InfoShop | June 18, 1998 |
“This Summary of Project Information is prepared and distributed to the public in advance of consideration of the proposed transaction by the Corporation’s Board of Directors. It is provided for the purpose of enhancing the transparency of IFC’s activities and should not be construed as presuming the outcome of IFC Board consideration.”
For Additional Information contact: Corporate Relations Unit -
telephone: (202) 473-7711
facsimile: (202) 974-4384
Environmental documents for this project are available at http://www.ifc.org and from the World Bank InfoShop (http://www.worldbank.org/html/pic/aboutinfo.html).
Sponsor / Cost / Location
Related ESRS/ERS
